Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudwaleit

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Arthritis and Rheumatism|April 3, 2008
Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugsI H Song, D A Poddubnyy, M Rudwaleit, et al.
Annals of the Rheumatic Diseases|March 24, 2004
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitisM Rudwaleit, J Listing, J Brandt, et al.
Annals of the Rheumatic Diseases|November 13, 2004
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitisJ Zou, H Appel, M Rudwaleit, et al.
American Journal of Nephrology|January 1, 1996
Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapyM Rudwaleit, A Schwarz, C Trautmann, et al.
Zeitschrift Fur Rheumatologie|June 30, 2004
[Diagnosis of reactive arthritis]H Haibel, M Rudwaleit, J Sieper, et al.
Zeitschrift Fur Rheumatologie|March 2, 2011
[Advice for patients diagnosed with ankylosing spondylitis: results of a representative patient survey in Germany]E Feldtkeller, L Hammel, C Brenneis, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritisD A Poddubnyy, M Rudwaleit, J Listing, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanerceptJ Zou, M Rudwaleit, J Brandt, et al.
Arthritis and Rheumatism|November 18, 2000
Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritisV Moos, M Rudwaleit, V Herzog, et al.
Rheumatology (Oxford, England)|July 19, 2003
Treatment of active ankylosing spondylitis with pamidronateH Haibel, J Brandt, M Rudwaleit, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Arthritis and Rheumatism|April 3, 2008
Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugsI H Song, D A Poddubnyy, M Rudwaleit, et al.
Annals of the Rheumatic Diseases|March 24, 2004
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitisM Rudwaleit, J Listing, J Brandt, et al.
Annals of the Rheumatic Diseases|November 13, 2004
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitisJ Zou, H Appel, M Rudwaleit, et al.
American Journal of Nephrology|January 1, 1996
Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapyM Rudwaleit, A Schwarz, C Trautmann, et al.
Zeitschrift Fur Rheumatologie|June 30, 2004
[Diagnosis of reactive arthritis]H Haibel, M Rudwaleit, J Sieper, et al.
Zeitschrift Fur Rheumatologie|March 2, 2011
[Advice for patients diagnosed with ankylosing spondylitis: results of a representative patient survey in Germany]E Feldtkeller, L Hammel, C Brenneis, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritisD A Poddubnyy, M Rudwaleit, J Listing, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanerceptJ Zou, M Rudwaleit, J Brandt, et al.
Arthritis and Rheumatism|November 18, 2000
Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritisV Moos, M Rudwaleit, V Herzog, et al.
Rheumatology (Oxford, England)|July 19, 2003
Treatment of active ankylosing spondylitis with pamidronateH Haibel, J Brandt, M Rudwaleit, et al.
Pageof 14